Abstract Submission Deadline: Undergraduate Student Caucus and Poster Competition:February 29, 2024 Regular Abstract Titles and Texts Posted to Online Itinerary Planner: March 5, 2024(4:30 p.m. ET) Late-Breaking and Clinical Trials Abstract Titles Posted to Online Itinerary Planner March 5, 2024:...
标题： IBI3001，一种潜在全球首创（First-in-Class）的糖基化定点偶联 B7-H3/EGFR 双抗ADC 在多项临床前实体瘤模型中的表现摘要号：LB055展示形式：壁报时间：2024年4月7日（星期日） 1：30 PM – 5：00 PM （当地时间）地点：Poster Section 53讲者：何开杰博士IBI3001是一款潜在全球首创针对B7-H3和EGFR...
IBI343,一种定点偶联抗Claudin18.2 ADC用于治疗实体瘤,临床前发现及特征摘要号:LB057展示形式:壁报时间:2024年4月7日(星期日) 1:30 PM – 5:00 PM (当地时间)地点:Poster Section 53讲者:何开杰博士壁报展示会议类别:免疫学-单抗和双抗 标题:兼具高效抗肿瘤活性和可接受安全性的新型 TROP2 靶向免疫刺激抗体...
Clinical Trials Poster Session 1 I期临床试验 摘要号:CT055 / 5 英文标题:Efficacy of YK-029A, a novel EGFR TKI, in advanced NSCLC patients with acquired T790M mutation 中文标题:YK-029A(一种新型EGFR TKI)在具有获得性T790M突变的晚期...
(serplulimab) as first-line treatment for patients with extensive-stage small cell lung cancer (ES-SCLC) was published as poster presentation at the American Association for Cancer Research 2024 meeting (AACR 2024), with Professor Ying Cheng from Jilin Province Cancer Hospital as the leading ...
2024年第115届美国癌症研究协会(AACR)年会于当地时间4月5日至10日在圣地亚哥盛大召开,汇集了肿瘤领域众多前沿研究成果和创新进展。本次盛会,世和基因2项研究成果入选口头报告(Mini Oral)、11项入选壁报(Poster)。这13项研究基于多组学技术,对多癌种早筛、MRD技术创新与应用、ctDNA液体活检多场景临床应用以及多组学生...
我院甲状腺乳腺外科林豪雨副主任,梁元科副主任医师受邀参与并进行了两项研究成果的Poster学术汇报:“Molecular Mechanism of CD146 Nanobody in Tumor Metastasis Inhibition mediating by IL-6/JAK/STAT3 signaling in Triple-negative Breast Ca...
Late-Breaking and Clinical Trials Abstract Withdrawal Deadline:February 23, 2024 - LBA和临床试验摘要撤回截止日期 Abstract Submission Deadline: Undergraduate Student Caucus and Poster Competition:February 29, 2024 Regular Abstract Titles and Texts Posted to Online Itinerary Planner: March 5, 2024(4:30...
2024年4月8日(星期一)HMPL-295 (一种强效、选择性的 ERK1/2 抑制剂) 的临床前特征 Preclinical characterization of HMPL-295, a potent and selective ERK1/2 inhibitor胡佳,和黄医药,中国上海#1661 海报展示 | Poster Session (PO.MCB03.01 – Cell Signaling Components as Therapeutic Targets) ...
Late-Breaking Poster Session 摘要号:LB266 / 11 英文标题:AMG510-mediated inactivation of BCL-xL protein promotes Gasdermin-E-dependent pyroptosis in KRAS-G12C mutant non-small cell lung cancer 中文标题:AMG510介导的BCL-xL蛋白失活促进KRAS-G12C突变非小细胞肺癌中Gasdermin-E依赖性细胞焦亡 ...